Kezar Life Sciences, Inc.KZRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank33
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-56.64M
↓ 35% vs avg
Percentile
P33
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-41.93M
Historical baseline
PeriodValueYoY Change
TTM$-56.64M+23.7%
2024$-74.21M+9.1%
2023$-81.64M-38.7%
2022$-58.85M-38.7%
2021$-42.44M-14.9%
2020$-36.95M-23.7%
2019$-29.88M-43.7%
2018$-20.79M-156.4%
2017$-8.11M+16.9%
2016$-9.76M-